Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma company to pair with the Crohn's and Colitis Foundation of America.
The NYT reports that the data on gaming long-term memory is inconclusive.
The Mario Bros. company says health and fun are the way of the future.
The Kimberly-Clark-backed cold and flu predictor mixes Big Data, and big branding, with an individualized focus.
Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
The EpiduoTap app offers rewards for sticking with the acne-controlling medication.
Publisher UBM spurs medical competition among psychiatrists, Bayer says it's keeping its diabetes division.
Boehringer Ingelheim is hoping to create a new Facebook phenomenon with the development of a pharma civilization game that could give industry reputation a shot in the arm.
Bayer Diabetes Care partnered with Nintendo on a glucose meter for kids that incorporates gaming.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.